Clinical application and research progress of 225Ac for tumor targeted therapy / 中华核医学与分子影像杂志
Chinese Journal of Nuclear Medicine and Molecular Imaging
; (6): 52-54, 2023.
Article
de Zh
| WPRIM
| ID: wpr-993557
Bibliothèque responsable:
WPRO
ABSTRACT
In recent years, the application of alpha particle-based nuclide targeted therapy in tumors has shown great potential. 225Ac is a nuclide that can be used for alpha radionuclide targeted therapy which has been studied at home and abroad. A number of preclinical and clinical trials have been carried out, and some achievements have been obtained. This article summarizes the current research status of several malignant tumors, and analyzes the challenges and progress faced by 225Ac in radionuclide targeted therapy.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chinese Journal of Nuclear Medicine and Molecular Imaging
Année:
2023
Type:
Article